PharmaShots | Incisive News in 3 Shots

Subscribe Now

Menarini Group

Menarini Group and Stemline Therapeutics Receive EC’s Approval for Orserdu (elacestrant) to Treat ER+, HER2- Locally Advanced or Metastatic Breast Cancer

Menarini Group and Stemline Therapeutics Receive EC’s Approval for Orserdu (elacestrant) to Treat ER+, HER2- Locally Advanced or M...

September 20, 2023

Menarini Group and Stemline Therapeutics Receive EMA’s CHMP Positive Opinion of Orserdu (elacestrant) for ER+, HER2- Locally Advanced or Metastatic Breast Cancer

Menarini Group and Stemline Therapeutics Receive EMA’s CHMP Positive Opinion of Orserdu (elacestrant) for ER+, HER2- Locally Advan...

July 24, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us